The Venture Codex Logo

The Venture Codex

Overview

Targeted cancer immunotherapies and therapeutic cancer vaccines.

Total Raised

$33 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Therapeutics

Investment History

  1. Series B

    Oct 2024

    $33M

Team

Kevin Pojasek

President, CEO & Board Director

George Kassiotis

Co-founder

Drew Mark Pardoll

Co-founder

Houman Ashrafian

Co-Founder & Chairman Of The Board